Vaccine makers surge on race to develop coronavirus treatment
27/01/2020 16:13
(Updates)
** Shares of vaccine developers Inovio Pharmaceuticals
INO.O , Novavax Inc NVAX.O and Moderna Inc MRNA.O gain as
companies race to develop a treatment for coronavirus
** Stocks rise in sharp contrast to a broader decline in
U.S. stocks due to rising fears of a financial fallout after
virus outbreak
** INO up ~20%, on track to extend a two-day winning streak;
NVAX up 2% and MRNA 13%
** Vir Biotechnology Inc VIR.O up ~30%, set to extend
three-day rally after co says their library of
infection-fighting proteins effective against other
coronaviruses
** Other vaccine makers such as Vaccinex Inc VCNX.O ,
Vaxart Inc VXRT.O jump 52% and 22%, respectively
** Shares of BioCryst Pharmaceuticals Inc BCRX.O rise ~5%
as co testing an antiviral, galidesivir, in early-stage clinical
trials
** Shares of face mask maker Alpha Pro Tech Ltd APT.A up
20.7% at $7.24
** Meridian Bioscience's shares VIVO.O surge 35.9% to
$12.95 after it said its reagent mix is being used in China to
develop virus screening tests urn:newsml:reuters.com:*:nGNX1vLMz0
** Co-Diagnostics Inc CODX.O shares surge ~53%, extending
gains from last week after co designs a virus-screening test
(Reporting by Manas Mishra in Bengaluru)
((Manas.Mishra@thomsonreuters.com; within U.S. +1 646 223 8780,
outside U.S. +91 806749 8325))